Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 2019

View Archived Issues

Brain kinase induces spinal cord regeneration

Microfluidics method broadens human iPSC potential

Brain regulatory T cells potentiate neurological recovery

Oppilan Pharma initiates phase I study of OPL-002

Regulus announces clinical candidate nomination for RGLS-5579 for GBM

Oncolys BioPharma initiates phase II study of Telomelysin in combination with pembrolizumab

Patient enrollment begins in phase II study of CPI-613 in Burkitt lymphoma/leukemia

Kymab initiates phase II study of KY-1005 in atopic dermatitis

Patient recruitment ongoing in first-in-human study of IBI-101

Georgia State University describes new carbon monoxide-releasing molecules

Tarlige tablets receive approval in Japan for the treatment of peripheral neuropathic pain

Inovio initiates first-in-human study of DNA-encoded monoclonal antibody for Zika

The General Hospital Corp. patents new CYP1 inhibitors

Combining novel MCL-1 inhibitor with MEK inhibitors as promising new strategy in KRAS-mutant NSCLC

Genentech and Roche disclose IRAK-4 inhibitors

Medshine Discovery presents TLR8 agonists

CX-23, an NQO1-selective activated prodrug of triptolide, shows promise in preclinical models of HCC

Chinese researchers identify compounds for estrogen receptor-mediated diseases

Spero and Everest Medicines sign license and option agreements for SPR-206 and SPR-741 in Asia

Japan first to approve Evenity for osteoporosis

MediciNova opens enrollment in phase I/II study of MN-166 with temozolomide in GBM

Demser approved in Japan to improve catecholamine excess secretion in patients with pheochromocytoma

Japanese approval for Braftovi and Mektovi for unresectable melanoma with BRAF mutation

Wockhardt presents first clinical data for WCK-5222 in patients with renal impairment

IAVI initiates phase I trial of BG505 SOSIP.664 gp140 in HIV-uninfected subjects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...